Synthetic Biology grants in Canada

Closed

Supports biosecurity research, policy work, and prevention planning for pandemic preparedness.

Closed

Funds preclinical translational research advancing therapies for inherited retinal degeneration and dry AMD.

Closed

Funds organizations designing and early-stage testing of new vaccine candidates against CEPI priority pathogens and Disease X viral families, with awards up to $1M over 18 months.

Closed

Funds organizations conducting preclinical vaccine development for CEPI priority pathogens and Disease X exemplars through CEPI's Innovations call.

Closed

Funds accredited research institutions developing treatments for congenital dystroglycanopathies with grants up to $50,000.

Closed

Funds accredited research institutions developing treatments and care improvements for congenital-onset laminopathies with grants up to $100,000.

Closed

Funds global teams developing drug, biologic, dietary, or microbiome-based interventions that target placental and gut inflammatory pathways to improve fetal growth outcomes in low-income countries.

Closed

Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.

Closed

Funds developing and validating gene-editing tools in animal and other model systems used to study the human brain.

Closed

Runs a 10-week, no-cost, non-dilutive accelerator for early-stage security, resiliency, and dual-use founders, from Pre-Seed through Series A+, culminating in enterprise pilots and investor-ready pitches.

Closed

Funds global teams researching novel approaches to overcome infection, inflammation, and microbiome-related barriers that reduce the effectiveness of food fortification programs.

Open

Funds partnerships of universities, research institutes and businesses to jointly run doctoral training programmes for early-career researchers.

Open

Awards women founders and co-founders across three prize categories, from EUR 20,000 up to EUR 100,000, for leading breakthrough European innovations.

Scheduled

Funds cross-sector consortia building 'talent ecosystems' that connect researcher training with employer needs to make early research careers more attractive.

Scheduled

Funds consortia running youth science-engagement programmes or researcher-public dialogue events under one of two chosen tracks to boost trust in science.

Scheduled

Funds a group of 3-6 cities to jointly run a year-long 'Science comes to town' public-engagement programme, including the EUCYS and EU TalentOn competitions.

Scheduled

Funds part of the cost of talent-recruitment programmes that give postdoctoral researchers a two-phase path to a stable research career in Europe.

Scheduled

Funds part of the cost of running new or existing doctoral training programmes at universities and research organisations.

Scheduled

Funds city and regional authorities to run living labs that scale up circular-economy solutions across Europe.

Scheduled

Funds European Researchers' Night events and Researchers at Schools visits that bring MSCA-funded scientists face to face with the public and pupils.

Scheduled

Funds complementary services, synergies and integration across Europe’s major research infrastructures.

Scheduled

Funds individual support to a single ESFRI Landmark or European Research Infrastructure Consortium to strengthen, evolve or sustain a pan-European research infrastructure.

Scheduled

Funds public buyers to test and procure breakthrough solutions with experimentation spaces and regulators.

Scheduled

Funds research into the structural causes of Europe's 15-year decline in youth maths, reading and science skills.